Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.15 per share a year ago. These ...
For the past five years, researchers at WVU have been developing microwave technology that could change the way everyday ...
The rise in connectivity heightens the potential of cybersecurity breaches and data theft, particularly with IoT-enabled devices that relay sensitive ... Wireless Network Connectivity), By End-User ...
Bovine collagen, valued for biocompatibility and versatility, is gaining attention for medical devices in China as regulatory ...
University of B.C. researchers have developed a coating that could make medical devices safer for millions of patients, ...
SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...
Trump’s hardline nationalism will also not go amiss, and could play a key role in defining US-China relations in the near ...
Baird Small/Mid Cap Growth portfolio increased +6.9% in 3Q, net of fees, compared to the +7.0% increase in our primary ...
The Medical Devices sector report provides comprehensive information ... reviews the major players involved in the development of Transmucosal Drug Delivery and list all their pipeline projects 3.2 ...
With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
The "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback